Malignant tumor of cervix
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results revealed that CC tissues had higher levels of iRhom1 and iRhom2 than adjacent normal tissues.
|
31661139 |
2020 |
Cervix carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results revealed that CC tissues had higher levels of iRhom1 and iRhom2 than adjacent normal tissues.
|
31661139 |
2020 |
cervical cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The results revealed that CC tissues had higher levels of iRhom1 and iRhom2 than adjacent normal tissues.
|
31661139 |
2020 |
Adenomatous Polyposis Coli
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, through overexpression and silencing of RHBDF1 and the mediator complex, our study demonstrates that RHBDF1 may positively regulate adenomatous polyposis coli (APC) in the Wnt/β-catenin signalling pathway to increase the expression levels of MMP-14 and Twist, which act as important epithelial-to-mesenchymal transition (EMT) stimulating factors.
|
29654741 |
2018 |
Atrial Premature Complexes
|
0.010 |
Biomarker
|
disease |
BEFREE |
RHBDF1 regulates APC-mediated stimulation of the epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells in part via the Wnt/β-catenin signalling pathway.
|
29654741 |
2018 |
Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using a genetic screen, we found that the presence of either iRhom1 or iRhom2 lacking part of their extended amino-terminal cytoplasmic domain (herein referred to as ΔN) increases ADAM17 activity, TNFR shedding, and resistance to TNF-induced cell death in fibrosarcoma cells.
|
26535007 |
2015 |
Adult Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using a genetic screen, we found that the presence of either iRhom1 or iRhom2 lacking part of their extended amino-terminal cytoplasmic domain (herein referred to as ΔN) increases ADAM17 activity, TNFR shedding, and resistance to TNF-induced cell death in fibrosarcoma cells.
|
26535007 |
2015 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing the RHBDF1 gene with short interfering RNA (siRNA) results in apoptosis in breast cancer MDA-MB-435 cells and autophagy in head and neck squamous cell cancer 1483 cells.
|
18524845 |
2008 |
Malignant Head and Neck Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RHBDF1 mRNA level is significantly elevated in clinical specimens of invasive ductal carcinoma of the breast, and the protein is readily detectable in human breast cancer or head and neck cancer cell lines.
|
18524845 |
2008 |
Malignant Squamous Cell Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing the RHBDF1 gene with short interfering RNA (siRNA) results in apoptosis in breast cancer MDA-MB-435 cells and autophagy in head and neck squamous cell cancer 1483 cells.
|
18524845 |
2008 |
Invasive Ductal Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RHBDF1 mRNA level is significantly elevated in clinical specimens of invasive ductal carcinoma of the breast, and the protein is readily detectable in human breast cancer or head and neck cancer cell lines.
|
18524845 |
2008 |
Head and Neck Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RHBDF1 mRNA level is significantly elevated in clinical specimens of invasive ductal carcinoma of the breast, and the protein is readily detectable in human breast cancer or head and neck cancer cell lines.
|
18524845 |
2008 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
|
16885366 |
2006 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
|
16885366 |
2006 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We examined ERRP expression and localisation in surgical specimens of gastric cancers from 47 patients versus non-malignant gastric mucosa and determined their relationship to cell proliferation and differentiation.
|
15647181 |
2005 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Disseminated Malignant Neoplasm
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Because of the causal involvement of EGFR and its ligands in gastric cancer growth, we investigated expression of ERRP and cell proliferation in human gastric cancer.
|
15647181 |
2005 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer.
|
15647181 |
2005 |
Carcinogenesis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.
|
15327841 |
2004 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.
|
15205570 |
2004 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Epidermal growth factor receptor-related protein expression was found to be high in benign human colonic epithelium but low in adenocarcinoma.
|
12730874 |
2003 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein-induced inhibition of proliferation of colon cancer cells was prevented by epidermal growth factor receptor-related protein antibodies.
|
12730874 |
2003 |
Cardiac Arrest
|
0.010 |
Biomarker
|
disease |
BEFREE |
Intratumoral or subcutaneous (away from the tumor site) injections of purified epidermal growth factor receptor-related protein caused regression of palpable colon cancer xenograft tumors in some severely compromised immunodeficient mice and arrested tumor growth in others.
|
12730874 |
2003 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor-related protein-induced inhibition of proliferation of colon cancer cells was prevented by epidermal growth factor receptor-related protein antibodies.
|
12730874 |
2003 |